Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 16, 2005 - Issue 1
Submit an article Journal homepage
234
Views
36
CrossRef citations to date
0
Altmetric
Original article

Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): Results of an open‐label, paired‐comparison, clinical trial

F. Dall'Oglio Dermatology Clinic, University of Catania, Catania, ItalyCorrespondence[email protected]
,
M. R. Nasca Institute of Hygiene, Catholic University, Rome, Italy
,
M. L. Musumeci Dermatology Clinic, University La Sapienza, Rome, Italy
,
G. La Torre Dermatology Clinic, University of Catania, Catania, ItalyCorrespondence[email protected]
,
G. Ricciardi Institute of Hygiene, Catholic University, Rome, Italy
,
C. Potenza Dermatology Clinic, University La Sapienza, Rome, Italy
&
G. Micali Dermatology Clinic, University of Catania, Catania, ItalyCorrespondence[email protected]
 show all
Pages 10-14 | Received 26 May 2004, Accepted 13 Aug 2004, Published online: 12 Jul 2009

References

  • Perret CM, Happle R. Treatment of alopecia areata. In: Orfanos CE, Happle R, editors. Hair and Hair Disease. Springer-Verlag: Berlin Heidelberg, 1990:571–86.
  • Shapiro J. Topical immunotherapy in the treatment of chronic alopecia areata. Dermatol Clin 1993;1:619–22.
  • Micali G, Licastro Cicero R, Nasca MR, et al. Treatment of alopecia areata with squaric acid dibutylester. Int J Dermatol 1996;35:52–6.
  • Rokhsar CK, Shupack JL, Vafai JJ, et al. Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 1998;39:751–61.
  • Buckley DA, Du Vivier AWP. The therapeutic use of topical contact sensitizers in benign dermatoses. Br J Dermatol 2001;145:385–456.
  • Tosti A, De Padova MP, Minghetti G, et al. Therapies versus placebo in the treatment of patchy alopecia areata. J Am Acad Dermatol 1986;15:209–10.
  • Swanson NA, Mitchell AJ, Leahy MS, et al. Topical treat- ment of alopecia areata. Arch Dermatol 1986;117:384–7.
  • Chua SH, Goh CL, Ang CB. Topical squaric acid dibuty- lester therapy for alopecia areata: a double-sided patient- controlled study. Ann Acad Med Singapore 1996;25:842–7.
  • Olsen E, Hordinsky M, McDonald-Hull S, et al. Alopecia areata investigational assesssment guidelines. J Am Acad Dermatol 1990;40:242–6.
  • Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:459–66.
  • MacDonald Hull S, Pepall L, Cunliffe WJ. Alopecia areata in children: response to treatment with diphencyprone. Br J Dermatol 1991;125:164–8.
  • Mitchell AJ, Krull EA. Alopecia areata: pathogenesis and treatment. J Am Acad Dermatol 1984;11:763–75.
  • Roselino AMF, Almeida AM, Hippolito MA, et al. Clinical- epidemiologic study of alopecia areata. Int J Dermatol 1996;35:181–4.
  • Happle R, Kalveram KJ, Bu¨ chner U, et al. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester. Dermatologica 1980;161:289–97.
  • Case PC, Mitchell AJ, Swanson NA, et al. Topical therapy of alopecia areata with squaric acid dibutylester. J Am Acad Dermatol 1984;10:447–51.
  • Bart JH, Darley CR, Gibson JR. Squaric acid dibutyl ester in the treatment of alopecia areata. Dermatologica 1985; 170:40–2.
  • Caserio RJ. Treatment of alopecia areata with squaric acid dibutylester. Arch Dermatol 1987;123:1036–41.
  • Iijima S. Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibuty- lester. Arch Dermatol 1997;133:539–40.
  • Naldi L, Parazzini F, Cainelli T, and the Reading Group. Role of topical immunotherapy in the treatment of alopecia areata. J Am Acad Dermatol 1990;22:654–6.
  • Pigatto PD, Rapisarda R, Polenghi MM, et al. Studio controllato dell’efficacia dell’immunoterapia topica nell’alopecia areata: acido squarico versus placebo. Giorn It Dermatol Venereol 1987;122:667–70.
  • Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549–66.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.